U.S. Micro‑Solutions is committed to advancing the accuracy, efficiency, and compliance of bacterial endotoxin testing (BET) for the industries we serve. In collaboration with Charles River, our laboratory conducted a comprehensive, side‑by‑side evaluation of the Endosafe® nexgen‑MCS™ cartridge‑based platform and the Sievers Eclipse system. This three‑day study, involving 120 spiked water samples, compared the platforms’ performance across critical criteria, including low‑endotoxin sensitivity, workflow simplicity, turnaround time, and alignment with stringent standards such as ANSI/AAMI ST108 and USP <85>.
The results highlight meaningful differences between cartridge‑based and microplate‑based testing approaches—and underscore the importance of choosing validated methods that deliver both accuracy and operational efficiency. As a full‑service contract testing laboratory, U.S. Micro‑Solutions brings this same level of rigor, scientific expertise, and data‑driven decision‑making to every project we perform. Whether you require ultrapure water analysis, medical device testing, or ongoing compliance support, our team provides reliable results with the responsiveness and collaboration you expect from a trusted partner.
Read the full case study here: Validating BET Methods for Ultrapure and Critical Water
